Is Nicotine an Effective Treatment for ADHD? Three Studies Weigh In
The Carlat Child Psychiatry Report, Volume 2, Number 5, August 2011
Editor-in-Chief, Caroline Fisher, PhD, MD
If you want to watch a new drug wend its way to market, you might start watching the literature for ABT-809, a nicotinic receptor partial agonist and proposed novel approach to the treatment of ADHD.
Editor-in-Chief, Caroline Fisher, PhD
Training director and Chief of Child Psychiatry at Samaritan Health Systems in Corvallis, OR
Dr. Fisher has disclosed that she has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.